about
Protein binding of isofluorophate in vivo after coexposure to multiple chemicalsImpact of fossil fuel emissions on atmospheric radiocarbon and various applications of radiocarbon over this centuryCerebral aneurysms: formation, progression, and developmental chronologyOpportunities in low-level radiocarbon microtracing: applications and new technologyBiological/biomedical accelerator mass spectrometry targets. 1. optimizing the CO2 reduction step using zinc dust.Design of a secondary ionization target for direct production of a C(-) beam from CO2 pulses for online AMSQuality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.Improving tritium exposure reconstructions using accelerator mass spectrometry.Calculating radiation exposures during use of (14)C-labeled nutrients, food components, and biopharmaceuticals to quantify metabolic behavior in humansAccelerator mass spectrometry-enabled studies: current status and future prospects.Human vitamin B12 absorption measurement by accelerator mass spectrometry using specifically labeled (14)C-cobalamin.Use of microdosing and accelerator mass spectrometry to evaluate the pharmacokinetic linearity of a novel tricyclic GyrB/ParE inhibitor in ratsQuantifying exploratory low dose compounds in humans with AMS.Isotope-labeled immunoassays without radiation wasteAttomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry.Progress in personalizing chemotherapy for bladder cancerDetermining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry.Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans.Recent advances in biomedical applications of accelerator mass spectrometry.Quantifying Carbon-14 for Biology Using Cavity Ring-Down Spectroscopy.DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.Early human ADME using microdoses and microtracers: bioanalytical considerations.Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials.Accelerator MS: its role as a frontline bioanalytical technique.Applications of accelerator MS in pediatric drug evaluation.Maternal exposure to an environmentally relevant dose of triclocarban results in perinatal exposure and potential alterations in offspring development in the mouse model.Use of accelerator mass spectrometry for studies in nutrition.Absorption and retinol equivalence of beta-carotene in humans is influenced by dietary vitamin A intake.The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs.Application of (14)C-accelerator MS in pharmaceutical development.Recent applications of a single quadrupole mass spectrometer in C, F and radiometal chemistry
P2860
Q24812951-1DEC13FB-CFE7-4850-BC17-CC017359388AQ28611314-45B8B633-198F-43EA-902D-FD59F1C4CDD6Q28649596-14EADBEC-BBC4-4414-9627-EC77F7BD8189Q28817904-3616DE09-3680-4B45-BD4C-ECE91F41A14AQ33368790-9C9E14EF-DADD-42DF-9DD5-3EA49D678FA0Q33648315-9D45FF70-9EBB-4312-8E18-0DCB50B8890DQ33723177-81088F55-34B7-4A8A-A442-431F84E41BDAQ33761017-DA2B4386-72C1-4529-B40F-B3A77F339FA2Q33803400-393ACBC7-07DD-4B32-9BCC-E4E418F1BDF7Q33819361-74B84950-C04C-4226-A6EF-9ABD211909DEQ34595866-BEC7802A-4492-4960-8850-14C21A52B256Q34596727-55584658-A5EB-4BA5-8689-97AE153FC256Q34708648-0CCE87A3-1370-4439-A9E8-87946B133E9CQ35073607-3FFC0ABC-A4F6-4F87-A1CE-1987A50BC8BBQ35252821-1D6E4250-566D-41D4-8747-8CCEA689AD59Q35779460-ABA4B0EE-EDA3-4D4D-A083-14E77370C4AFQ36402145-05481F43-86FC-4A3A-8430-A2E585FA4C50Q36798273-700A5AD8-F6EE-47FC-82DF-F648B571A928Q37266360-9DFA481B-1999-4988-BA76-6B74774E79CAQ37600860-F0F9C33C-108F-4B06-904C-156485B57FB5Q37736567-222DA27C-6510-4C52-ADB5-D092FC384541Q37810137-46B09BDD-0904-4144-BAAE-084DF4FA748EQ37810234-972C0103-3119-40EF-BC77-B1041EEE5761Q37964571-72F5B51E-F6B1-41EF-9231-18F90EA71441Q37970117-1B46622E-8B3D-4B93-BD9A-50BFF9C81756Q38040176-6798D12D-8683-4249-A5D2-1930C1BD2380Q38632251-47E4C4CF-5152-4D99-AD65-54FC52642B57Q40674194-724FE982-7886-411A-84F7-3B1DECF9413DQ44460198-F1F957BE-CA73-4AD2-BEED-8D80AF92FF9EQ46950790-C0B2FB92-9BEE-451A-9F7B-E5FFBE46A391Q53226670-7AC7CB69-1236-4DF2-9115-648EDFA9C5B4Q58573414-EA6F9FB2-D8B8-453C-AE45-934AFDD8FE00
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Accelerator mass spectrometry.
@en
type
label
Accelerator mass spectrometry.
@en
prefLabel
Accelerator mass spectrometry.
@en
P2093
P356
P1433
P1476
Accelerator mass spectrometry.
@en
P2093
P304
P356
10.1021/AC00107A001
P407
P577
1995-06-01T00:00:00Z